Gould Robert J
Insider CIK 1577034 · EPZM President and CEO, Director · FULC See Remarks, Director, 10% owner · TSBX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-02 | 32,000 | — | $0 | 32,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 15,000 | $10.72 | $160.8K | 454,864 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-01-06 | 15,000 | $11.87 | $178.1K | 469,864 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2026-01-02 | 2026-02-04 | 15,000 | $10.87 | $163.1K | 469,864 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-21 | 15,000 | $11.03 | $165.4K | 484,864 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2025-06-26 | 2025-06-30 | 36,000 | — | $0 | 36,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TSBX Turnstone Biologics Corp. | A Award deriv | 2024-06-03 | 2024-07-02 | 12,770 | — | $0 | 12,770 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2023-06-27 | 2023-06-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2023-01-13 | 2023-01-13 | 6,766 | $15.00 | $101.5K | 499,864 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2022-06-27 | 2022-06-29 | 19,000 | — | $0 | 19,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-06-07 | 2022-06-08 | 71,435 | — | $0 | 86,523 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-06-07 | 2022-06-08 | 71,435 | $7.84 | $560.1K | 578,065 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-06-07 | 2022-06-08 | 71,435 | $8.09 | $577.9K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-06-06 | 2022-06-06 | 24,382 | — | $0 | 157,958 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-06-06 | 2022-06-06 | 24,382 | $7.84 | $191.2K | 531,012 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-06-06 | 2022-06-06 | 24,382 | $8.10 | $197.5K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-06-03 | 2022-06-06 | 25,551 | — | $0 | 182,340 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-06-03 | 2022-06-06 | 25,551 | $7.84 | $200.3K | 532,181 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-06-03 | 2022-06-06 | 25,551 | $7.95 | $203.1K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-06-02 | 2022-06-06 | 16,689 | — | $0 | 207,891 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-06-02 | 2022-06-06 | 16,689 | $7.84 | $130.8K | 523,319 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-06-02 | 2022-06-06 | 16,689 | $7.92 | $132.2K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-04-07 | 2022-04-11 | 5,631 | — | $0 | 224,580 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-04-07 | 2022-04-11 | 5,631 | $7.84 | $44.1K | 512,261 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-04-07 | 2022-04-11 | 5,631 | $24.02 | $135.3K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-04-05 | 2022-04-05 | 52,552 | — | $0 | 230,211 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-04-05 | 2022-04-05 | 52,552 | $7.84 | $412.0K | 559,182 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-04-05 | 2022-04-05 | 52,552 | $24.26 | $1.27M | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-04-04 | 2022-04-05 | 7,235 | — | $0 | 282,763 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-04-04 | 2022-04-05 | 7,235 | $7.84 | $56.7K | 513,865 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-04-04 | 2022-04-05 | 7,235 | $24.02 | $173.8K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise deriv | 2022-04-01 | 2022-04-05 | 34,464 | — | $0 | 289,998 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2022-04-01 | 2022-04-05 | 34,464 | $24.03 | $828.2K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | M Exercise | 2022-04-01 | 2022-04-05 | 34,464 | $7.84 | $270.2K | 541,094 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2021-03-16 | 2021-03-17 | 789 | $12.43 | $9.8K | 506,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2021-03-15 | 2021-03-17 | 9,211 | $12.13 | $111.7K | 507,419 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 1,673 | $14.56 | $24.4K | 516,630 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2021-02-16 | 2021-02-18 | 6,542 | $14.19 | $92.8K | 518,303 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2021-02-02 | 2021-02-04 | 269,390 | — | $0 | 269,390 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 10,000 | $12.08 | $120.8K | 524,845 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-07-08 | 2020-07-09 | 2,500 | $20.00 | $50.0K | 534,845 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-25 | 2020-06-26 | 2,500 | $20.80 | $52.0K | 537,345 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-09 | 2020-06-10 | 156 | $20.00 | $3.1K | 539,845 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-05 | 2020-06-09 | 3,433 | $20.17 | $69.2K | 540,001 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-04 | 2020-06-05 | 1,300 | $20.04 | $26.1K | 543,434 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 1,500 | $20.13 | $30.2K | 544,734 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-02 | 2020-06-03 | 2,797 | $20.00 | $55.9K | 546,234 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 5 | $20.00 | $100 | 549,031 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-29 | 2020-06-01 | 1,390 | $20.08 | $27.9K | 549,036 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-28 | 2020-06-01 | 1,919 | $20.01 | $38.4K | 550,426 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-05-26 | 2020-05-28 | 2,500 | $20.00 | $50.0K | 552,345 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2020-02-19 | 2020-02-20 | 2,500 | $20.00 | $50.0K | 554,845 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2020-01-23 | 2020-01-27 | 200,000 | — | $0 | 200,000 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | A Award deriv | 2019-07-18 | 2019-07-18 | 107,142 | — | $0 | 107,142 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2015-12-30 | 2015-12-31 | 11,805 | — | $0 | 355,115 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-12-30 | 2015-12-31 | 11,805 | $18.02 | $212.7K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2015-12-30 | 2015-12-31 | 11,805 | $0.51 | $6.0K | 11,805 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2015-12-29 | 2015-12-31 | 20,303 | — | $0 | 366,920 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2015-12-29 | 2015-12-31 | 20,303 | $0.51 | $10.4K | 20,303 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-12-29 | 2015-12-31 | 20,303 | $18.01 | $365.7K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2015-09-08 | 2015-09-10 | 60,000 | — | $0 | 387,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-09-08 | 2015-09-10 | 700 | $19.25 | $13.5K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2015-09-08 | 2015-09-10 | 60,000 | $0.51 | $30.6K | 60,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-09-08 | 2015-09-10 | 59,300 | $19.87 | $1.18M | 700 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2015-08-03 | 2015-08-05 | 60,000 | — | $0 | 447,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-08-03 | 2015-08-05 | 55,800 | $21.94 | $1.22M | 4,200 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-08-03 | 2015-08-05 | 4,200 | $22.40 | $94.1K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2015-08-03 | 2015-08-05 | 60,000 | $0.51 | $30.6K | 60,000 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2015-07-06 | 2015-07-08 | 60,000 | — | $0 | 507,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-07-06 | 2015-07-08 | 15,142 | $23.64 | $358.0K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2015-07-06 | 2015-07-08 | 60,000 | $0.51 | $30.6K | 60,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2015-07-06 | 2015-07-08 | 44,858 | $23.07 | $1.03M | 15,142 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2015-02-13 | 2015-02-17 | 97,579 | — | $0 | 97,579 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-11-03 | 2014-11-04 | 30,000 | — | $0 | 567,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-11-03 | 2014-11-04 | 24,094 | $24.77 | $596.8K | 5,906 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-11-03 | 2014-11-04 | 5,506 | $25.64 | $141.2K | 400 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-11-03 | 2014-11-04 | 400 | $26.44 | $10.6K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-11-03 | 2014-11-04 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-10-01 | 2014-10-03 | 30,000 | — | $0 | 597,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-10-01 | 2014-10-03 | 500 | $27.06 | $13.5K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-10-01 | 2014-10-03 | 29,500 | $26.26 | $774.7K | 500 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-10-01 | 2014-10-03 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-09-02 | 2014-09-04 | 30,000 | — | $0 | 627,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-09-02 | 2014-09-04 | 23,033 | $33.35 | $768.2K | 6,967 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-09-02 | 2014-09-04 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-09-02 | 2014-09-04 | 6,967 | $33.85 | $235.8K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-08-01 | 2014-08-05 | 30,000 | — | $0 | 657,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-01 | 2014-08-05 | 19,820 | $29.96 | $593.8K | 10,180 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-01 | 2014-08-05 | 10,180 | $30.78 | $313.3K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-08-01 | 2014-08-05 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-07-01 | 2014-07-03 | 30,000 | — | $0 | 687,223 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-07-01 | 2014-07-03 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-07-01 | 2014-07-03 | 29,600 | $31.52 | $933.0K | 400 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-07-01 | 2014-07-03 | 400 | $31.89 | $12.8K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-06-02 | 2014-06-04 | 30,000 | — | $0 | 717,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-06-02 | 2014-06-04 | 1,200 | $23.34 | $28.0K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-06-02 | 2014-06-04 | 28,800 | $22.15 | $637.9K | 1,200 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-06-02 | 2014-06-04 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-05-01 | 2014-05-05 | 30,000 | — | $0 | 747,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-05-01 | 2014-05-05 | 1,913 | $22.28 | $42.6K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-05-01 | 2014-05-05 | 28,087 | $21.89 | $614.8K | 1,913 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-05-01 | 2014-05-05 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-04-07 | 2014-04-08 | 30,000 | — | $0 | 777,223 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-04-07 | 2014-04-08 | 30,000 | $0.51 | $15.3K | 30,000 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-04-07 | 2014-04-08 | 30,000 | $20.22 | $606.6K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-02-10 | 2014-02-12 | 60,000 | — | $0 | 807,223 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-12 | 60,000 | $29.25 | $1.75M | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-02-10 | 2014-02-12 | 60,000 | $0.51 | $30.6K | 60,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2014-01-28 | 2014-01-30 | 54,813 | — | $0 | 54,813 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-01-02 | 2014-01-06 | 3,334 | — | $0 | 867,223 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-01-02 | 2014-01-06 | 14,131 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise deriv | 2014-01-02 | 2014-01-06 | 12,535 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-01-02 | 2014-01-06 | 12,535 | $20.16 | $252.7K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-01-02 | 2014-01-06 | 3,334 | $20.18 | $67.3K | 0 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-01-02 | 2014-01-06 | 12,535 | $0.30 | $3.8K | 12,535 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-01-02 | 2014-01-06 | 3,334 | $0.51 | $1.7K | 3,334 | SEC↗ |
| EPZM Epizyme, Inc. | M Exercise | 2014-01-02 | 2014-01-06 | 14,131 | $0.33 | $4.7K | 14,131 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-01-02 | 2014-01-06 | 14,131 | $20.16 | $284.9K | 0 | SEC↗ |